Insights
Benchmark International Successfully Facilitated the Transaction Between Medius AG and regenold GmbH
June 20, 2024
Benchmark International is pleased to announce the acquisition of Medius by regenold.
Medius, based near Basel, Switzerland, was founded in 1997 by Dr. Urs Rickenbacher and is a consulting and service firm for medical and healthcare products. As a marketing authorization holder, it assists companies in marketing their products in Switzerland and other countries.
Founded in 1994, regenold offers a full suite of regulatory services from development to market access and life cycle management for pharmaceuticals, medical devices, cosmetics, food supplements and other products. Headquartered in Badenweiler, Germany, regenold serves an international client base supported by its subsidiaries in the UK, Switzerland and Portugal, along with its proprietary network, regulanet.
To increase its presence in Switzerland and to support Medius’s national and international growth, regenold acquired a majority stake in Medius from founder and owner Dr. Rickenbacher, who will remain on board as managing shareholder.
Dr. Rickenbacher commented on the transaction: “With regenold, I am very glad to have found a strategic partner with long-term growth prospects who will ensure the continued existence and further development of Medius. I would like to thank Benchmark for their ongoing support and expert advice throughout the whole M&A transaction process.”
Dr. Max Regenold said about the deal: “regenold has been operating successfully in Switzerland for several years with various services in the pharmaceutical and medical products sector. We see a growing demand for services from Swiss customers in the biotech sector, among others. This has led regenold to the decision to expand our business in Switzerland with local qualified resources and extended domain expertise. Medius AG, with its broad expertise, a strong customer base, and a Swissmedic approved establishment license ideally complements regenold in this respect.”
Share This Post
Categories
Get These Insights Delivered Directly To Your Email
Explore our curated collection today and stay ahead of the curve in M&A.
Verwandte Artikel
Benchmark International Announces Tyrus O’Neill as New Chief Executive Officer (CEO) of the AmericasTAMPA, FL – 03/14/2025 – Benchmark International, a leading global mergers and acquisitions (M&A) advisory firm, is excited to announce Tyrus O’Neill as the new Chief Executive Officer (CEO) of the Americas. The appointment is part of Benchmark International’s ongoing strategy to accelerate its global growth and service innovation.Erwartungen für Fusionen und Übernahmen im mittleren Marktsegment im Jahr 2025Jüngste Umfragen haben gezeigt, dass die M&A-Aussichten für das Jahr 2025 den größten Optimismus der letzten Jahre in Bezug auf Geschäftsabschlüsse erkennen lassen. Die 14. jährliche Umfrage der Citizens Bank unter mehr als 400 Führungskräften des Mittelstands und Private-Equity-Investoren in den Vereinigten Staaten ergab, dass ein günstiges wirtschaftliches Umfeld ein Hauptgrund dafür ist, dass Unternehmen und Investoren im Jahr 2025 nach M&A-Strategien suchen werden. Außerdem haben sich die Unsicherheiten der letzten Jahre gelegt, und die Bewertungen werden als stabil oder höher als in den vergangenen Jahren eingeschätzt. Kleinere mittelständische Unternehmen gehen indes zurückhaltender vor, und viele Verkäufer entscheiden sich für den Verkauf eines Teils ihres Unternehmens und nicht für einen Komplettverkauf. Zusammenfassend lässt sich sagen, dass die befragten Entscheidungsträger für das Jahr 2025 ein Wirtschaftswachstum und eine höhere Rate an M&A-Transaktionen erwarten.